Venus Remedies Limited

The drug is used to treat urinary tract infections (pyelonephritis, cystitis), gonorrhea, lower respiratory tract infections (pneumonia, bronchitis), bacteremia, meningitis, infections of the bones, joints, skin, and soft tissues, intra-abdominal infections (peritonitis), and gynecological infections.

Dosage form: powder for injection solution or infusion solution

ATC: J01DF01

The drug is used for the treatment of squamous cell carcinoma of the head, neck, and cervix, Hodgkin's disease and non-Hodgkin's lymphomas, testicular cancer, as well as for palliative therapy in malignant pleural effusion.

Dosage form: lyophilisate for solution for injection

ATC: L01DC01

The drug is used for the treatment of epithelial ovarian cancer and small cell lung cancer. It may be used either as a monotherapy or in combination with other antineoplastic agents.

Dosage form: solution for injection

ATC: L01XA02

The drug is used to treat widespread or metastatic cancer of the testis, ovary, bladder, lungs (small cell and non-small cell), as well as squamous cell carcinoma of the head and neck. It is also used for the treatment of cervical tumors in combination with other agents or radiotherapy.

Dosage form: concentrate for infusion solution

ATC: L01XA01

The drug is used to treat widespread or metastatic cancer of the testis, ovary, bladder, non-small cell and small cell lung cancer, as well as squamous cell carcinoma of the head and neck. It is also used for the treatment of cervical tumors in combination with radiotherapy.

Dosage form: concentrate for infusion solution

ATC: L01XA01

The drug is used for chemotherapy of various types of tumors, including acute lymphoblastic leukemia, Hodgkin's disease, non-Hodgkin lymphomas, breast cancer, ovarian cancer, small cell lung cancer, Ewing sarcoma, osteosarcoma, and other malignant neoplasms. It is also used for certain severe autoimmune diseases (lupus nephritis, Wegener's granulomatosis).

Dosage form: lyophilisate for solution for injection

ATC: L01AA01

The drug is used for chemotherapy of various types of tumors, including acute lymphoblastic leukemia, Hodgkin's disease, non-Hodgkin's lymphomas, breast cancer, ovarian cancer, lung cancer, as well as for preparation for bone marrow transplantation and the treatment of certain autoimmune diseases.

Dosage form: lyophilisate for solution for injection

ATC: L01AA01

The drug is used to achieve and maintain remission in acute non-lymphoblastic leukemias in adults and children, as well as for the treatment of other types of leukemia (e.g., acute lymphocytic or chronic myeloblastic leukemia). It is also used in combination therapy for non-Hodgkin lymphomas in children.

Dosage form: solution for injection

ATC: L01BC01

Dacarbazine is used for the treatment of malignant metastatic melanoma. It is also used as part of combination therapy for Hodgkin's disease and progressive soft tissue sarcoma in adults.

Dosage form: lyophilisate for solution for injection

ATC: L01AX04

The drug is used for the treatment of malignant metastatic melanoma, as well as as part of combination therapy for Hodgkin's disease and progressive soft tissue sarcoma in adults.

Dosage form: lyophilisate for solution for injection

ATC: L01AX04

The drug is prescribed for the treatment of various types of cancer: breast cancer (adjuvant therapy or treatment of metastatic cancer), non-small cell lung cancer, prostate cancer (metastatic castration-resistant or hormone-sensitive), gastric adenocarcinoma, and head and neck cancer.

Dosage form: concentrate for infusion solution

ATC: L01CD02

The drug is used to treat a wide range of oncological diseases, including acute leukemia, lymphoma, soft tissue sarcoma, and osteosarcoma, as well as tumors in children and solid tumors in adults (e.g., breast and lung cancer).

Dosage form: solution for injection

ATC: L01DB01

The drug is used for the treatment of small cell lung cancer, non-seminomatous testicular carcinoma, acute myelomonocytic and myelocytic leukemia, as well as for palliative therapy of non-small cell lung cancer, Hodgkin's disease, non-Hodgkin's lymphoma, and choriocarcinomas.

Dosage form: concentrate for infusion solution

ATC: L01CB01

The drug is used for the treatment of breast cancer, colorectal cancer, stomach cancer, pancreatic cancer, as well as head and neck cancer.

Dosage form: solution for injection

ATC: L01BC02

The drug is used to treat various types of tumors, including testicular tumors, breast cancer, cervical carcinoma, non-small cell and small cell bronchial carcinoma, soft tissue sarcoma (including osteosarcoma and rhabdomyosarcoma), Ewing sarcoma, as well as certain types of non-Hodgkin lymphomas and Hodgkin's disease.

Dosage form: powder for solution for infusion

ATC: L01AA06

The drug is used to treat complicated infections of the intra-abdominal cavities, severe pneumonia (including hospital-acquired), urinary tract, skin, and soft tissue infections, as well as intranatal and postpartum infections. It is also used for bacteremia and in patients with neutropenia accompanied by fever.

Dosage form: powder for solution for infusion

ATC: J01DH51

The drug is intended for the treatment of adults and children from 1 year of age for complicated intra-abdominal infections, severe pneumonia (including hospital-acquired), intranatal and postpartum infections, complicated urinary tract, skin, and soft tissue infections, as well as bacteremia.

Dosage form: powder for solution for infusion

ATC: J01DH51

The drug is used to treat patients with metastatic colorectal cancer. It may be prescribed as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine) depending on the stage and previous treatment.

Dosage form: concentrate for infusion solution

ATC: L01CE02

The drug is used to protect the body from the toxic effects of methotrexate (specifically in osteosarcoma), to reduce intoxication in cases of overdose with methotrexate or other similar agents, and to treat megaloblastic anemia caused by folic acid deficiency. It is also used in combination with 5-fluorouracil for the treatment of colorectal cancer.

Dosage form: solution for injection

ATC: V03AF03

The drug is used to treat severe pneumonia, bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, acute bacterial meningitis, as well as infections during and after childbirth. It is also used for febrile neutropenia and bacteremia.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is used to treat severe pneumonia, bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intestinal (intra-abdominal) infections, skin and soft tissue infections, as well as infections during and after childbirth, acute bacterial meningitis, and bacteremia. It can also be used in febrile neutropenia.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is prescribed for the treatment of severe pneumonia, bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, acute bacterial meningitis, as well as infections during and after childbirth. It is also used in the treatment of patients with febrile neutropenia and bacteremia.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is used to treat severe infections in adults and children from 3 months of age, specifically: severe pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, acute bacterial meningitis, as well as infections during and after childbirth. It is also used for bronchopulmonary infections in people with cystic fibrosis and in febrile neutropenia.

Dosage form: powder for injection solution or infusion solution

ATC: J01DH02

The drug is used to treat ovarian cancer, breast cancer, advanced non-small cell lung cancer, and Kaposi's sarcoma in patients with AIDS.

Dosage form: concentrate for infusion solution

ATC: L01CD01

The drug is used to treat a wide range of infections caused by bacteria. Specifically, it is applied for respiratory tract infections (pneumonia, bronchitis), urinary tract infections (pyelonephritis, cystitis), abdominal cavity infections (peritonitis), skin, bone, and joint infections, as well as for septicemia, bacterial meningitis, and gonorrhea.

Dosage form: powder for injection solution

ATC: J01DA

The drug is used to treat a wide range of infections caused by bacteria, including respiratory tract infections (pneumonia, bronchitis), abdominal cavity infections (peritonitis), urinary tract infections (pyelonephritis, cystitis), skin, bone, and joint infections, urogenital system infections, as well as bacterial meningitis and septicemia.

Dosage form: powder for injection solution

ATC: J01DA

The drug is used to treat a wide range of infections in adults and children from 1 year of age, including: nosocomial pneumonia, bacterial meningitis, complicated urinary tract, skin, soft tissue, and abdominal infections, bone and joint infections, as well as peritonitis and bacteremia.

Dosage form: powder for injection solution

ATC: J01RA

The drug is used to treat a wide range of infections in adults and children from 1 year of age, including: nosocomial pneumonia, bacterial meningitis, complicated urinary tract, skin, soft tissue, and abdominal cavity infections, bone and joint infections, as well as for the prevention of infections during certain surgical procedures.

Dosage form: powder for injection solution

ATC: J01RA

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs).

Dosage form: concentrate for infusion solution

ATC: L01XA03

The drug is used in combination with 5-fluorouracil and folinic acid for adjuvant therapy of stage III colorectal cancer (after tumor removal) or for the treatment of metastatic colorectal cancer.

Dosage form: solution for injection

ATC: L01XA03

The drug is used for the treatment of ovarian cancer, breast cancer, advanced non-small cell lung cancer, as well as Kaposi's sarcoma in patients with AIDS.

Dosage form: concentrate for infusion solution

ATC: L01CD01

The drug is used to treat bacterial septicemia, respiratory tract infections (e.g., pneumonia), skin infections, urinary tract infections (pyelonephritis), bone and joint infections (osteomyelitis, arthritis), abdominal organ infections (peritonitis, cholecystitis), meningitis, as well as for burns.

Dosage form: powder for injection solution

ATC: J01DE01

The drug is prescribed for the treatment of pneumonia (hospital-acquired and community-acquired), bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, infections during and after childbirth, as well as acute bacterial meningitis. It can also be used in febrile neutropenia.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is prescribed for the treatment of pneumonia (hospital-acquired and community-acquired), bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, infections during and after childbirth, as well as acute bacterial meningitis. It can also be used in febrile neutropenia.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is prescribed for the treatment of pneumonia (hospital-acquired and community-acquired), bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, as well as acute bacterial meningitis. It can also be used for infections during or after childbirth and for patients with neutropenic fever.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is prescribed for the treatment of pneumonia (hospital-acquired and community-acquired), bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, infections during and after childbirth, as well as acute bacterial meningitis. It can also be used in febrile neutropenia.

Dosage form: powder for injection solution

ATC: J01DH02

The drug is used to treat various bacterial infections, including respiratory tract, skin, soft tissue, kidney, urinary tract, bone, joint, and abdominal organ infections, as well as meningitis, gonorrhea, and syphilis, and for the prevention of infections in surgery.

Dosage form: powder for injection solution

ATC: J01DD54

The drug is used to treat a wide range of infections: respiratory tract infections, middle ear infections, soft tissue, skin, kidney, urinary tract, bone, and joint infections, as well as meningitis, gonorrhea, syphilis, and septicemia. It is also used for the prevention of infections in surgery.

Dosage form: powder for injection solution

ATC: J01DD54

The drug is used to treat various types of cancer, including acute leukemias, lymphomas, sarcomas, breast cancer, lung cancer, as well as idiopathic thrombocytopenic purpura.

Dosage form: solution for injection

ATC: L01CA02

The drug is used for the treatment of bile duct cancer, bladder cancer, breast cancer, non-small cell lung cancer, ovarian cancer, and pancreatic cancer.

Dosage form: powder for solution for infusion

ATC: L01BC05

The drug is used for the treatment of bile duct cancer, bladder cancer, breast cancer, non-small cell lung cancer, ovarian cancer, and pancreatic cancer.

Dosage form: powder for solution for infusion

ATC: L01BC05

The drug is used for the treatment of patients with advanced colorectal cancer. It may be used either as monotherapy or in combination with other medicinal products (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.

Dosage form: solution for injection

ATC: L01XX19